Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Heart Failure × acalabrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Recurrence 1 Lymphoma, Mantle-Cell 1 Lymphatic Diseases 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Heart Failure 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 obinutuzumab 1 acalabrutinib 1 Spironolactone 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06651970 2026-02-23

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting

LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡